Clorox (CLX) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, CLX trades at $94.57 with a market cap of $11.22B and a P/E ratio of 15.38. CLX moved +1.70% today. Year to date, CLX is -6.93%; over the trailing twelve months it is -30.44%. Its 52-week range spans $84.70 to $171.37. Analyst consensus is neutral with an average price target of $100.23. Rallies surfaces CLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent CLX insider activity includes Breber Pierre R bought 5.00K and Breber Pierre R bought 4.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $94.57 |
| Market Cap | $11.22B |
| P/E Ratio | 15.38 |
| EPS | $6.14 |
| Dividend Yield | 1.24% |
| 52-Week High | $171.37 |
| 52-Week Low | $84.70 |
| Volume | 2.04M |
| Avg Volume | 0 |
| Revenue (TTM) | $6.76B |
| Net Income | $770.00M |
| Gross Margin | 44.19% |
13 analysts cover CLX: 0 strong buy, 1 buy, 8 hold, 4 sell, 0 strong sell. Consensus rating is neutral. Average price target: $100.23.